InvestorsHub Logo
Post# of 250026
Next 10
Followers 58
Posts 11315
Boards Moderated 0
Alias Born 07/16/2006

Re: None

Monday, 10/05/2020 6:23:54 AM

Monday, October 05, 2020 6:23:54 AM

Post# of 250026
Bristol-Myers to buy MyoKardia for $13.1B, or $225/share in cash, WSJ reports

Bristol-Myers (BMY) will buy MyoKardia (MYOK) for $225 a share in cash, or $13.1B, The Wall Street Journal's Jared S. Hopkins reports.

MyoKardia's lead pipeline drug, code-named mavacamten, treats a chronic heart condition that can cause irregular heart rhythms in some patients and even death. Bristol plans to ask U.S. health regulators next year to approve the drug, Bristol CEO Giovanni Caforio says.

Read more at:

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.